nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A1—Cladribine—multiple sclerosis	0.134	0.222	CbGbCtD
Clonidine—CYP2D6—Fingolimod—multiple sclerosis	0.0598	0.0993	CbGbCtD
Clonidine—ABCB1—Methylprednisolone—multiple sclerosis	0.0409	0.0679	CbGbCtD
Clonidine—CYP1A1—Dexamethasone—multiple sclerosis	0.0396	0.0658	CbGbCtD
Clonidine—CYP3A4—Fingolimod—multiple sclerosis	0.0381	0.0631	CbGbCtD
Clonidine—ABCB1—Mitoxantrone—multiple sclerosis	0.0299	0.0495	CbGbCtD
Clonidine—ABCB1—Betamethasone—multiple sclerosis	0.0266	0.0442	CbGbCtD
Clonidine—ABCB1—Prednisolone—multiple sclerosis	0.0263	0.0436	CbGbCtD
Clonidine—ABCB1—Prednisone—multiple sclerosis	0.0248	0.0411	CbGbCtD
Clonidine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0245	0.0407	CbGbCtD
Clonidine—CYP3A5—Dexamethasone—multiple sclerosis	0.0238	0.0395	CbGbCtD
Clonidine—CYP3A4—Triamcinolone—multiple sclerosis	0.0186	0.0308	CbGbCtD
Clonidine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0179	0.0297	CbGbCtD
Clonidine—CYP3A4—Betamethasone—multiple sclerosis	0.0159	0.0265	CbGbCtD
Clonidine—CYP3A4—Prednisolone—multiple sclerosis	0.0157	0.0261	CbGbCtD
Clonidine—ABCB1—Dexamethasone—multiple sclerosis	0.0155	0.0257	CbGbCtD
Clonidine—CYP3A4—Prednisone—multiple sclerosis	0.0149	0.0247	CbGbCtD
Clonidine—CYP2D6—Dexamethasone—multiple sclerosis	0.0146	0.0242	CbGbCtD
Clonidine—ABCB1—Methotrexate—multiple sclerosis	0.0124	0.0206	CbGbCtD
Clonidine—CYP3A4—Dexamethasone—multiple sclerosis	0.00927	0.0154	CbGbCtD
Clonidine—SLC6A2—nerve—multiple sclerosis	0.00196	0.0576	CbGeAlD
Clonidine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00178	0.0523	CbGeAlD
Clonidine—NISCH—medulla oblongata—multiple sclerosis	0.00114	0.0335	CbGeAlD
Clonidine—NISCH—midbrain—multiple sclerosis	0.00104	0.0306	CbGeAlD
Clonidine—NISCH—spinal cord—multiple sclerosis	0.00102	0.0298	CbGeAlD
Clonidine—SLC6A2—brainstem—multiple sclerosis	0.000842	0.0247	CbGeAlD
Clonidine—NISCH—cerebellum—multiple sclerosis	0.000805	0.0237	CbGeAlD
Clonidine—ADRA1A—brainstem—multiple sclerosis	0.000783	0.023	CbGeAlD
Clonidine—ADRA1B—nervous system—multiple sclerosis	0.00073	0.0214	CbGeAlD
Clonidine—ADRA1D—nervous system—multiple sclerosis	0.000714	0.021	CbGeAlD
Clonidine—ADRA1B—central nervous system—multiple sclerosis	0.000703	0.0206	CbGeAlD
Clonidine—SLC22A5—retina—multiple sclerosis	0.000689	0.0203	CbGeAlD
Clonidine—ADRA1D—central nervous system—multiple sclerosis	0.000687	0.0202	CbGeAlD
Clonidine—SLC22A4—spinal cord—multiple sclerosis	0.000671	0.0197	CbGeAlD
Clonidine—NISCH—brain—multiple sclerosis	0.000654	0.0192	CbGeAlD
Clonidine—SLC6A2—medulla oblongata—multiple sclerosis	0.000587	0.0173	CbGeAlD
Clonidine—ADRA1B—brain—multiple sclerosis	0.000558	0.0164	CbGeAlD
Clonidine—ADRA1D—brain—multiple sclerosis	0.000546	0.016	CbGeAlD
Clonidine—SLC22A1—nervous system—multiple sclerosis	0.000539	0.0158	CbGeAlD
Clonidine—SLC22A4—cerebellum—multiple sclerosis	0.000532	0.0156	CbGeAlD
Clonidine—ADRA2C—medulla oblongata—multiple sclerosis	0.00052	0.0153	CbGeAlD
Clonidine—SLC22A1—central nervous system—multiple sclerosis	0.000518	0.0152	CbGeAlD
Clonidine—SLC22A3—nervous system—multiple sclerosis	0.000515	0.0151	CbGeAlD
Clonidine—SLC22A5—medulla oblongata—multiple sclerosis	0.000498	0.0146	CbGeAlD
Clonidine—SLC22A3—central nervous system—multiple sclerosis	0.000496	0.0146	CbGeAlD
Clonidine—ADRA2C—midbrain—multiple sclerosis	0.000475	0.014	CbGeAlD
Clonidine—ADRA2C—spinal cord—multiple sclerosis	0.000464	0.0136	CbGeAlD
Clonidine—CYP2D6—brainstem—multiple sclerosis	0.000461	0.0135	CbGeAlD
Clonidine—SLC22A5—midbrain—multiple sclerosis	0.000455	0.0134	CbGeAlD
Clonidine—SLC22A5—spinal cord—multiple sclerosis	0.000444	0.0131	CbGeAlD
Clonidine—SLC6A2—nervous system—multiple sclerosis	0.000441	0.013	CbGeAlD
Clonidine—SLC22A4—brain—multiple sclerosis	0.000432	0.0127	CbGeAlD
Clonidine—SLC6A2—central nervous system—multiple sclerosis	0.000425	0.0125	CbGeAlD
Clonidine—ADRA2A—medulla oblongata—multiple sclerosis	0.000415	0.0122	CbGeAlD
Clonidine—SLC22A1—brain—multiple sclerosis	0.000412	0.0121	CbGeAlD
Clonidine—ADRA1A—nervous system—multiple sclerosis	0.00041	0.012	CbGeAlD
Clonidine—ADRA1A—central nervous system—multiple sclerosis	0.000395	0.0116	CbGeAlD
Clonidine—SLC22A3—brain—multiple sclerosis	0.000393	0.0116	CbGeAlD
Clonidine—ADRA2C—nervous system—multiple sclerosis	0.000391	0.0115	CbGeAlD
Clonidine—ADRA1A—cerebellum—multiple sclerosis	0.000386	0.0113	CbGeAlD
Clonidine—ADRA2A—midbrain—multiple sclerosis	0.000379	0.0111	CbGeAlD
Clonidine—ADRA2C—central nervous system—multiple sclerosis	0.000376	0.0111	CbGeAlD
Clonidine—ADRA2A—spinal cord—multiple sclerosis	0.00037	0.0109	CbGeAlD
Clonidine—ADRA2C—cerebellum—multiple sclerosis	0.000368	0.0108	CbGeAlD
Clonidine—SLC22A5—cerebellum—multiple sclerosis	0.000352	0.0103	CbGeAlD
Clonidine—SLC6A2—brain—multiple sclerosis	0.000337	0.00991	CbGeAlD
Clonidine—CYP1A1—nervous system—multiple sclerosis	0.000334	0.00983	CbGeAlD
Clonidine—CYP1A1—central nervous system—multiple sclerosis	0.000322	0.00946	CbGeAlD
Clonidine—ABCB1—retina—multiple sclerosis	0.00032	0.0094	CbGeAlD
Clonidine—ADRA1A—brain—multiple sclerosis	0.000313	0.00921	CbGeAlD
Clonidine—ADRA2A—nervous system—multiple sclerosis	0.000312	0.00916	CbGeAlD
Clonidine—ADRA2A—central nervous system—multiple sclerosis	0.0003	0.00882	CbGeAlD
Clonidine—ADRA2C—brain—multiple sclerosis	0.000299	0.00878	CbGeAlD
Clonidine—ADRA2A—cerebellum—multiple sclerosis	0.000293	0.00862	CbGeAlD
Clonidine—SLC22A5—brain—multiple sclerosis	0.000286	0.00841	CbGeAlD
Clonidine—CYP1A1—brain—multiple sclerosis	0.000256	0.00751	CbGeAlD
Clonidine—Eye disorder—Prednisone—multiple sclerosis	0.000249	0.000912	CcSEcCtD
Clonidine—Anxiety—Methylprednisolone—multiple sclerosis	0.000249	0.00091	CcSEcCtD
Clonidine—Drowsiness—Methotrexate—multiple sclerosis	0.000248	0.000908	CcSEcCtD
Clonidine—Rash—Azathioprine—multiple sclerosis	0.000248	0.000907	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000248	0.000907	CcSEcCtD
Clonidine—Dermatitis—Azathioprine—multiple sclerosis	0.000248	0.000906	CcSEcCtD
Clonidine—Depression—Methotrexate—multiple sclerosis	0.000248	0.000906	CcSEcCtD
Clonidine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000247	0.000905	CcSEcCtD
Clonidine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000247	0.000905	CcSEcCtD
Clonidine—Discomfort—Triamcinolone—multiple sclerosis	0.000247	0.000904	CcSEcCtD
Clonidine—Discomfort—Methylprednisolone—multiple sclerosis	0.000247	0.000902	CcSEcCtD
Clonidine—Headache—Azathioprine—multiple sclerosis	0.000246	0.000901	CcSEcCtD
Clonidine—CYP3A4—nervous system—multiple sclerosis	0.000245	0.00721	CbGeAlD
Clonidine—Dry mouth—Triamcinolone—multiple sclerosis	0.000245	0.000895	CcSEcCtD
Clonidine—Angioedema—Dexamethasone—multiple sclerosis	0.000244	0.000891	CcSEcCtD
Clonidine—Angioedema—Betamethasone—multiple sclerosis	0.000244	0.000891	CcSEcCtD
Clonidine—Angiopathy—Prednisone—multiple sclerosis	0.000242	0.000885	CcSEcCtD
Clonidine—CYP2D6—nervous system—multiple sclerosis	0.000241	0.0071	CbGeAlD
Clonidine—Confusional state—Methylprednisolone—multiple sclerosis	0.000241	0.000883	CcSEcCtD
Clonidine—Malaise—Dexamethasone—multiple sclerosis	0.00024	0.000879	CcSEcCtD
Clonidine—Malaise—Betamethasone—multiple sclerosis	0.00024	0.000879	CcSEcCtD
Clonidine—Oedema—Triamcinolone—multiple sclerosis	0.00024	0.000877	CcSEcCtD
Clonidine—Syncope—Dexamethasone—multiple sclerosis	0.000239	0.000875	CcSEcCtD
Clonidine—Syncope—Betamethasone—multiple sclerosis	0.000239	0.000875	CcSEcCtD
Clonidine—ADRA2A—brain—multiple sclerosis	0.000238	0.007	CbGeAlD
Clonidine—Arrhythmia—Prednisone—multiple sclerosis	0.000238	0.000872	CcSEcCtD
Clonidine—Infection—Triamcinolone—multiple sclerosis	0.000238	0.000871	CcSEcCtD
Clonidine—Sweating—Methotrexate—multiple sclerosis	0.000238	0.000871	CcSEcCtD
Clonidine—Infection—Methylprednisolone—multiple sclerosis	0.000238	0.00087	CcSEcCtD
Clonidine—CYP3A4—central nervous system—multiple sclerosis	0.000236	0.00694	CbGeAlD
Clonidine—Shock—Triamcinolone—multiple sclerosis	0.000236	0.000863	CcSEcCtD
Clonidine—Insomnia—Prednisolone—multiple sclerosis	0.000236	0.000863	CcSEcCtD
Clonidine—Alopecia—Prednisone—multiple sclerosis	0.000236	0.000862	CcSEcCtD
Clonidine—Shock—Methylprednisolone—multiple sclerosis	0.000235	0.000861	CcSEcCtD
Clonidine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000235	0.000858	CcSEcCtD
Clonidine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000234	0.000857	CcSEcCtD
Clonidine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000234	0.000857	CcSEcCtD
Clonidine—Epistaxis—Methotrexate—multiple sclerosis	0.000234	0.000857	CcSEcCtD
Clonidine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000234	0.000857	CcSEcCtD
Clonidine—Paraesthesia—Prednisolone—multiple sclerosis	0.000234	0.000857	CcSEcCtD
Clonidine—Tachycardia—Triamcinolone—multiple sclerosis	0.000234	0.000856	CcSEcCtD
Clonidine—Mental disorder—Prednisone—multiple sclerosis	0.000234	0.000855	CcSEcCtD
Clonidine—Nausea—Azathioprine—multiple sclerosis	0.000233	0.000854	CcSEcCtD
Clonidine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000233	0.000854	CcSEcCtD
Clonidine—CYP2D6—central nervous system—multiple sclerosis	0.000232	0.00683	CbGeAlD
Clonidine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000232	0.00085	CcSEcCtD
Clonidine—Erythema—Prednisone—multiple sclerosis	0.000232	0.000849	CcSEcCtD
Clonidine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000232	0.000848	CcSEcCtD
Clonidine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000231	0.000846	CcSEcCtD
Clonidine—ABCB1—medulla oblongata—multiple sclerosis	0.000231	0.00679	CbGeAlD
Clonidine—Asthenia—Mitoxantrone—multiple sclerosis	0.000228	0.000834	CcSEcCtD
Clonidine—CYP2D6—cerebellum—multiple sclerosis	0.000227	0.00668	CbGeAlD
Clonidine—Anxiety—Dexamethasone—multiple sclerosis	0.000226	0.000827	CcSEcCtD
Clonidine—Anxiety—Betamethasone—multiple sclerosis	0.000226	0.000827	CcSEcCtD
Clonidine—Discomfort—Dexamethasone—multiple sclerosis	0.000224	0.00082	CcSEcCtD
Clonidine—Discomfort—Betamethasone—multiple sclerosis	0.000224	0.00082	CcSEcCtD
Clonidine—Hypotension—Methylprednisolone—multiple sclerosis	0.000224	0.000818	CcSEcCtD
Clonidine—Pain—Prednisolone—multiple sclerosis	0.000223	0.000816	CcSEcCtD
Clonidine—Hepatitis—Methotrexate—multiple sclerosis	0.000223	0.000815	CcSEcCtD
Clonidine—Vision blurred—Prednisone—multiple sclerosis	0.000219	0.0008	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000218	0.000799	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000218	0.000797	CcSEcCtD
Clonidine—Oedema—Dexamethasone—multiple sclerosis	0.000218	0.000796	CcSEcCtD
Clonidine—Oedema—Betamethasone—multiple sclerosis	0.000218	0.000796	CcSEcCtD
Clonidine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000217	0.000796	CcSEcCtD
Clonidine—Insomnia—Triamcinolone—multiple sclerosis	0.000217	0.000793	CcSEcCtD
Clonidine—Insomnia—Methylprednisolone—multiple sclerosis	0.000216	0.000792	CcSEcCtD
Clonidine—Infection—Betamethasone—multiple sclerosis	0.000216	0.000791	CcSEcCtD
Clonidine—Infection—Dexamethasone—multiple sclerosis	0.000216	0.000791	CcSEcCtD
Clonidine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000215	0.000788	CcSEcCtD
Clonidine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000215	0.000788	CcSEcCtD
Clonidine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000215	0.000786	CcSEcCtD
Clonidine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000215	0.000786	CcSEcCtD
Clonidine—Shock—Betamethasone—multiple sclerosis	0.000214	0.000783	CcSEcCtD
Clonidine—Shock—Dexamethasone—multiple sclerosis	0.000214	0.000783	CcSEcCtD
Clonidine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000214	0.000782	CcSEcCtD
Clonidine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000213	0.000781	CcSEcCtD
Clonidine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000213	0.000781	CcSEcCtD
Clonidine—Agitation—Prednisone—multiple sclerosis	0.000213	0.00078	CcSEcCtD
Clonidine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000213	0.000779	CcSEcCtD
Clonidine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000213	0.000779	CcSEcCtD
Clonidine—Tachycardia—Betamethasone—multiple sclerosis	0.000212	0.000777	CcSEcCtD
Clonidine—Tachycardia—Dexamethasone—multiple sclerosis	0.000212	0.000777	CcSEcCtD
Clonidine—Angioedema—Prednisone—multiple sclerosis	0.000212	0.000776	CcSEcCtD
Clonidine—ABCB1—midbrain—multiple sclerosis	0.000211	0.00621	CbGeAlD
Clonidine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00021	0.000769	CcSEcCtD
Clonidine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00021	0.000769	CcSEcCtD
Clonidine—Malaise—Prednisone—multiple sclerosis	0.000209	0.000766	CcSEcCtD
Clonidine—Eye disorder—Methotrexate—multiple sclerosis	0.000208	0.000762	CcSEcCtD
Clonidine—Syncope—Prednisone—multiple sclerosis	0.000208	0.000762	CcSEcCtD
Clonidine—Tinnitus—Methotrexate—multiple sclerosis	0.000208	0.00076	CcSEcCtD
Clonidine—Anorexia—Dexamethasone—multiple sclerosis	0.000207	0.000759	CcSEcCtD
Clonidine—Anorexia—Betamethasone—multiple sclerosis	0.000207	0.000759	CcSEcCtD
Clonidine—Urticaria—Prednisolone—multiple sclerosis	0.000207	0.000758	CcSEcCtD
Clonidine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000207	0.000757	CcSEcCtD
Clonidine—Fatigue—Triamcinolone—multiple sclerosis	0.000207	0.000756	CcSEcCtD
Clonidine—Fatigue—Methylprednisolone—multiple sclerosis	0.000206	0.000755	CcSEcCtD
Clonidine—ABCB1—spinal cord—multiple sclerosis	0.000206	0.00606	CbGeAlD
Clonidine—Pain—Triamcinolone—multiple sclerosis	0.000205	0.00075	CcSEcCtD
Clonidine—Loss of consciousness—Prednisone—multiple sclerosis	0.000204	0.000746	CcSEcCtD
Clonidine—Hypotension—Dexamethasone—multiple sclerosis	0.000203	0.000744	CcSEcCtD
Clonidine—Hypotension—Betamethasone—multiple sclerosis	0.000203	0.000744	CcSEcCtD
Clonidine—Angiopathy—Methotrexate—multiple sclerosis	0.000202	0.00074	CcSEcCtD
Clonidine—Vomiting—Mitoxantrone—multiple sclerosis	0.000202	0.000739	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000201	0.000735	CcSEcCtD
Clonidine—Rash—Mitoxantrone—multiple sclerosis	0.0002	0.000733	CcSEcCtD
Clonidine—Dermatitis—Mitoxantrone—multiple sclerosis	0.0002	0.000732	CcSEcCtD
Clonidine—Headache—Mitoxantrone—multiple sclerosis	0.000199	0.000728	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000198	0.000725	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000198	0.000725	CcSEcCtD
Clonidine—Arthralgia—Prednisone—multiple sclerosis	0.000198	0.000723	CcSEcCtD
Clonidine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000198	0.000723	CcSEcCtD
Clonidine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000197	0.000721	CcSEcCtD
Clonidine—Anxiety—Prednisone—multiple sclerosis	0.000197	0.000721	CcSEcCtD
Clonidine—Alopecia—Methotrexate—multiple sclerosis	0.000197	0.000721	CcSEcCtD
Clonidine—Insomnia—Betamethasone—multiple sclerosis	0.000197	0.00072	CcSEcCtD
Clonidine—Insomnia—Dexamethasone—multiple sclerosis	0.000197	0.00072	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000196	0.000718	CcSEcCtD
Clonidine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000196	0.000716	CcSEcCtD
Clonidine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000195	0.000715	CcSEcCtD
Clonidine—Paraesthesia—Betamethasone—multiple sclerosis	0.000195	0.000715	CcSEcCtD
Clonidine—Discomfort—Prednisone—multiple sclerosis	0.000195	0.000714	CcSEcCtD
Clonidine—Mental disorder—Methotrexate—multiple sclerosis	0.000195	0.000714	CcSEcCtD
Clonidine—Erythema—Methotrexate—multiple sclerosis	0.000194	0.00071	CcSEcCtD
Clonidine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000192	0.000703	CcSEcCtD
Clonidine—Urticaria—Triamcinolone—multiple sclerosis	0.00019	0.000697	CcSEcCtD
Clonidine—Urticaria—Methylprednisolone—multiple sclerosis	0.00019	0.000695	CcSEcCtD
Clonidine—Body temperature increased—Triamcinolone—multiple sclerosis	0.00019	0.000693	CcSEcCtD
Clonidine—Oedema—Prednisone—multiple sclerosis	0.000189	0.000693	CcSEcCtD
Clonidine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000189	0.000692	CcSEcCtD
Clonidine—Decreased appetite—Betamethasone—multiple sclerosis	0.000189	0.000692	CcSEcCtD
Clonidine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000189	0.000692	CcSEcCtD
Clonidine—Nausea—Mitoxantrone—multiple sclerosis	0.000189	0.000691	CcSEcCtD
Clonidine—Infection—Prednisone—multiple sclerosis	0.000188	0.000689	CcSEcCtD
Clonidine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000188	0.000687	CcSEcCtD
Clonidine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000188	0.000687	CcSEcCtD
Clonidine—Fatigue—Dexamethasone—multiple sclerosis	0.000188	0.000686	CcSEcCtD
Clonidine—Fatigue—Betamethasone—multiple sclerosis	0.000188	0.000686	CcSEcCtD
Clonidine—Shock—Prednisone—multiple sclerosis	0.000186	0.000682	CcSEcCtD
Clonidine—Pain—Dexamethasone—multiple sclerosis	0.000186	0.000681	CcSEcCtD
Clonidine—Pain—Betamethasone—multiple sclerosis	0.000186	0.000681	CcSEcCtD
Clonidine—Nervous system disorder—Prednisone—multiple sclerosis	0.000186	0.00068	CcSEcCtD
Clonidine—Tachycardia—Prednisone—multiple sclerosis	0.000185	0.000676	CcSEcCtD
Clonidine—CYP2D6—brain—multiple sclerosis	0.000185	0.00542	CbGeAlD
Clonidine—Skin disorder—Prednisone—multiple sclerosis	0.000184	0.000673	CcSEcCtD
Clonidine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000183	0.00067	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—multiple sclerosis	0.000183	0.000669	CcSEcCtD
Clonidine—Anorexia—Prednisone—multiple sclerosis	0.000181	0.000661	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00018	0.000659	CcSEcCtD
Clonidine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000179	0.000656	CcSEcCtD
Clonidine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000179	0.000656	CcSEcCtD
Clonidine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000178	0.000651	CcSEcCtD
Clonidine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000178	0.000651	CcSEcCtD
Clonidine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000177	0.000646	CcSEcCtD
Clonidine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000176	0.000645	CcSEcCtD
Clonidine—Malaise—Methotrexate—multiple sclerosis	0.000175	0.00064	CcSEcCtD
Clonidine—ABCB1—nervous system—multiple sclerosis	0.000174	0.00511	CbGeAlD
Clonidine—Urticaria—Dexamethasone—multiple sclerosis	0.000173	0.000632	CcSEcCtD
Clonidine—Urticaria—Betamethasone—multiple sclerosis	0.000173	0.000632	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000173	0.000632	CcSEcCtD
Clonidine—Dizziness—Prednisolone—multiple sclerosis	0.000172	0.000631	CcSEcCtD
Clonidine—Asthenia—Triamcinolone—multiple sclerosis	0.000172	0.000629	CcSEcCtD
Clonidine—Body temperature increased—Betamethasone—multiple sclerosis	0.000172	0.000629	CcSEcCtD
Clonidine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000172	0.000629	CcSEcCtD
Clonidine—Abdominal pain—Betamethasone—multiple sclerosis	0.000172	0.000629	CcSEcCtD
Clonidine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000172	0.000629	CcSEcCtD
Clonidine—Asthenia—Methylprednisolone—multiple sclerosis	0.000172	0.000628	CcSEcCtD
Clonidine—Insomnia—Prednisone—multiple sclerosis	0.000171	0.000627	CcSEcCtD
Clonidine—Paraesthesia—Prednisone—multiple sclerosis	0.00017	0.000622	CcSEcCtD
Clonidine—Pruritus—Triamcinolone—multiple sclerosis	0.00017	0.000621	CcSEcCtD
Clonidine—Cough—Methotrexate—multiple sclerosis	0.000169	0.000619	CcSEcCtD
Clonidine—Pruritus—Methylprednisolone—multiple sclerosis	0.000169	0.000619	CcSEcCtD
Clonidine—ABCB1—central nervous system—multiple sclerosis	0.000167	0.00492	CbGeAlD
Clonidine—Arthralgia—Methotrexate—multiple sclerosis	0.000165	0.000604	CcSEcCtD
Clonidine—Chest pain—Methotrexate—multiple sclerosis	0.000165	0.000604	CcSEcCtD
Clonidine—Decreased appetite—Prednisone—multiple sclerosis	0.000165	0.000603	CcSEcCtD
Clonidine—Rash—Prednisolone—multiple sclerosis	0.000164	0.000601	CcSEcCtD
Clonidine—Dermatitis—Prednisolone—multiple sclerosis	0.000164	0.000601	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000164	0.0006	CcSEcCtD
Clonidine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000164	0.000599	CcSEcCtD
Clonidine—ABCB1—cerebellum—multiple sclerosis	0.000163	0.0048	CbGeAlD
Clonidine—Fatigue—Prednisone—multiple sclerosis	0.000163	0.000598	CcSEcCtD
Clonidine—Headache—Prednisolone—multiple sclerosis	0.000163	0.000598	CcSEcCtD
Clonidine—Discomfort—Methotrexate—multiple sclerosis	0.000163	0.000597	CcSEcCtD
Clonidine—Constipation—Prednisone—multiple sclerosis	0.000162	0.000593	CcSEcCtD
Clonidine—Confusional state—Methotrexate—multiple sclerosis	0.00016	0.000584	CcSEcCtD
Clonidine—Dizziness—Triamcinolone—multiple sclerosis	0.000159	0.00058	CcSEcCtD
Clonidine—Dizziness—Methylprednisolone—multiple sclerosis	0.000158	0.000579	CcSEcCtD
Clonidine—Infection—Methotrexate—multiple sclerosis	0.000157	0.000575	CcSEcCtD
Clonidine—Feeling abnormal—Prednisone—multiple sclerosis	0.000156	0.000571	CcSEcCtD
Clonidine—Asthenia—Betamethasone—multiple sclerosis	0.000156	0.000571	CcSEcCtD
Clonidine—Asthenia—Dexamethasone—multiple sclerosis	0.000156	0.000571	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000155	0.000568	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000155	0.000567	CcSEcCtD
Clonidine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000155	0.000567	CcSEcCtD
Clonidine—Nausea—Prednisolone—multiple sclerosis	0.000155	0.000567	CcSEcCtD
Clonidine—Pruritus—Dexamethasone—multiple sclerosis	0.000154	0.000563	CcSEcCtD
Clonidine—Pruritus—Betamethasone—multiple sclerosis	0.000154	0.000563	CcSEcCtD
Clonidine—Skin disorder—Methotrexate—multiple sclerosis	0.000154	0.000563	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000153	0.00056	CcSEcCtD
Clonidine—Vomiting—Triamcinolone—multiple sclerosis	0.000152	0.000558	CcSEcCtD
Clonidine—Vomiting—Methylprednisolone—multiple sclerosis	0.000152	0.000556	CcSEcCtD
Clonidine—Rash—Triamcinolone—multiple sclerosis	0.000151	0.000553	CcSEcCtD
Clonidine—Dermatitis—Triamcinolone—multiple sclerosis	0.000151	0.000553	CcSEcCtD
Clonidine—Anorexia—Methotrexate—multiple sclerosis	0.000151	0.000552	CcSEcCtD
Clonidine—Rash—Methylprednisolone—multiple sclerosis	0.000151	0.000552	CcSEcCtD
Clonidine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000151	0.000551	CcSEcCtD
Clonidine—Urticaria—Prednisone—multiple sclerosis	0.00015	0.000551	CcSEcCtD
Clonidine—Headache—Triamcinolone—multiple sclerosis	0.00015	0.00055	CcSEcCtD
Clonidine—Headache—Methylprednisolone—multiple sclerosis	0.00015	0.000548	CcSEcCtD
Clonidine—Abdominal pain—Prednisone—multiple sclerosis	0.00015	0.000548	CcSEcCtD
Clonidine—Body temperature increased—Prednisone—multiple sclerosis	0.00015	0.000548	CcSEcCtD
Clonidine—Diarrhoea—Betamethasone—multiple sclerosis	0.000149	0.000545	CcSEcCtD
Clonidine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000149	0.000545	CcSEcCtD
Clonidine—Hypotension—Methotrexate—multiple sclerosis	0.000148	0.000541	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000144	0.000528	CcSEcCtD
Clonidine—Dizziness—Betamethasone—multiple sclerosis	0.000144	0.000526	CcSEcCtD
Clonidine—Dizziness—Dexamethasone—multiple sclerosis	0.000144	0.000526	CcSEcCtD
Clonidine—Insomnia—Methotrexate—multiple sclerosis	0.000143	0.000524	CcSEcCtD
Clonidine—Nausea—Triamcinolone—multiple sclerosis	0.000142	0.000521	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—multiple sclerosis	0.000142	0.00052	CcSEcCtD
Clonidine—Nausea—Methylprednisolone—multiple sclerosis	0.000142	0.00052	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—multiple sclerosis	0.000141	0.000516	CcSEcCtD
Clonidine—Somnolence—Methotrexate—multiple sclerosis	0.000141	0.000515	CcSEcCtD
Clonidine—Hypersensitivity—Prednisone—multiple sclerosis	0.00014	0.000511	CcSEcCtD
Clonidine—Vomiting—Dexamethasone—multiple sclerosis	0.000138	0.000506	CcSEcCtD
Clonidine—Vomiting—Betamethasone—multiple sclerosis	0.000138	0.000506	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—multiple sclerosis	0.000138	0.000504	CcSEcCtD
Clonidine—Rash—Betamethasone—multiple sclerosis	0.000137	0.000502	CcSEcCtD
Clonidine—Rash—Dexamethasone—multiple sclerosis	0.000137	0.000502	CcSEcCtD
Clonidine—Dermatitis—Betamethasone—multiple sclerosis	0.000137	0.000501	CcSEcCtD
Clonidine—Dermatitis—Dexamethasone—multiple sclerosis	0.000137	0.000501	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000137	0.0005	CcSEcCtD
Clonidine—Fatigue—Methotrexate—multiple sclerosis	0.000136	0.000499	CcSEcCtD
Clonidine—Headache—Betamethasone—multiple sclerosis	0.000136	0.000499	CcSEcCtD
Clonidine—Headache—Dexamethasone—multiple sclerosis	0.000136	0.000499	CcSEcCtD
Clonidine—Asthenia—Prednisone—multiple sclerosis	0.000136	0.000497	CcSEcCtD
Clonidine—Pain—Methotrexate—multiple sclerosis	0.000135	0.000495	CcSEcCtD
Clonidine—Pruritus—Prednisone—multiple sclerosis	0.000134	0.00049	CcSEcCtD
Clonidine—ABCB1—brain—multiple sclerosis	0.000133	0.0039	CbGeAlD
Clonidine—Feeling abnormal—Methotrexate—multiple sclerosis	0.00013	0.000477	CcSEcCtD
Clonidine—Diarrhoea—Prednisone—multiple sclerosis	0.00013	0.000474	CcSEcCtD
Clonidine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000129	0.000474	CcSEcCtD
Clonidine—Nausea—Dexamethasone—multiple sclerosis	0.000129	0.000473	CcSEcCtD
Clonidine—Nausea—Betamethasone—multiple sclerosis	0.000129	0.000473	CcSEcCtD
Clonidine—Urticaria—Methotrexate—multiple sclerosis	0.000126	0.00046	CcSEcCtD
Clonidine—Dizziness—Prednisone—multiple sclerosis	0.000125	0.000458	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—multiple sclerosis	0.000125	0.000458	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—multiple sclerosis	0.000125	0.000458	CcSEcCtD
Clonidine—Vomiting—Prednisone—multiple sclerosis	0.00012	0.000441	CcSEcCtD
Clonidine—Rash—Prednisone—multiple sclerosis	0.000119	0.000437	CcSEcCtD
Clonidine—Dermatitis—Prednisone—multiple sclerosis	0.000119	0.000437	CcSEcCtD
Clonidine—Headache—Prednisone—multiple sclerosis	0.000119	0.000434	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000117	0.000427	CcSEcCtD
Clonidine—Asthenia—Methotrexate—multiple sclerosis	0.000114	0.000416	CcSEcCtD
Clonidine—Nausea—Prednisone—multiple sclerosis	0.000113	0.000412	CcSEcCtD
Clonidine—Pruritus—Methotrexate—multiple sclerosis	0.000112	0.00041	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—multiple sclerosis	0.000108	0.000396	CcSEcCtD
Clonidine—Dizziness—Methotrexate—multiple sclerosis	0.000105	0.000383	CcSEcCtD
Clonidine—Vomiting—Methotrexate—multiple sclerosis	0.000101	0.000368	CcSEcCtD
Clonidine—Rash—Methotrexate—multiple sclerosis	9.98e-05	0.000365	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—multiple sclerosis	9.97e-05	0.000365	CcSEcCtD
Clonidine—Headache—Methotrexate—multiple sclerosis	9.92e-05	0.000363	CcSEcCtD
Clonidine—Nausea—Methotrexate—multiple sclerosis	9.4e-05	0.000344	CcSEcCtD
Clonidine—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	2.12e-05	0.000236	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	2.12e-05	0.000236	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.11e-05	0.000234	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	2.11e-05	0.000234	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.11e-05	0.000234	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PGR—multiple sclerosis	2.1e-05	0.000234	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	2.1e-05	0.000233	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	2.08e-05	0.000231	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	2.07e-05	0.00023	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.06e-05	0.000229	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCR3—multiple sclerosis	2.06e-05	0.000229	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CD28—multiple sclerosis	2.04e-05	0.000227	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	2.03e-05	0.000225	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—POMC—multiple sclerosis	2.03e-05	0.000225	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	2.02e-05	0.000224	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	2.01e-05	0.000223	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCR2—multiple sclerosis	2.01e-05	0.000223	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—CCL2—multiple sclerosis	1.98e-05	0.00022	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	1.98e-05	0.00022	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—POMC—multiple sclerosis	1.98e-05	0.00022	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CXCL10—multiple sclerosis	1.98e-05	0.00022	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	1.97e-05	0.000219	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	1.97e-05	0.000219	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.97e-05	0.000218	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	1.96e-05	0.000217	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	1.94e-05	0.000215	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.93e-05	0.000214	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	1.91e-05	0.000213	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.91e-05	0.000212	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—BCHE—multiple sclerosis	1.9e-05	0.000211	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.89e-05	0.000209	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	1.88e-05	0.000209	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	1.87e-05	0.000207	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.86e-05	0.000206	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.86e-05	0.000206	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	1.85e-05	0.000206	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	1.85e-05	0.000206	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	1.84e-05	0.000204	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	1.84e-05	0.000204	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	1.83e-05	0.000203	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.83e-05	0.000203	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	1.82e-05	0.000202	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—ALB—multiple sclerosis	1.81e-05	0.000201	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	1.8e-05	0.0002	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	1.8e-05	0.0002	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	1.8e-05	0.0002	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	1.8e-05	0.0002	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	1.79e-05	0.000199	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—IL2—multiple sclerosis	1.79e-05	0.000199	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	1.79e-05	0.000198	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	1.79e-05	0.000198	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	1.78e-05	0.000197	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	1.75e-05	0.000195	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	1.75e-05	0.000195	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.74e-05	0.000193	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.74e-05	0.000193	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	1.73e-05	0.000193	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	1.73e-05	0.000192	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	1.72e-05	0.000191	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	1.71e-05	0.00019	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	1.71e-05	0.00019	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	1.7e-05	0.000189	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.7e-05	0.000189	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	1.69e-05	0.000187	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	1.68e-05	0.000187	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	1.68e-05	0.000186	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	1.67e-05	0.000186	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	1.67e-05	0.000185	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	1.66e-05	0.000184	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	1.65e-05	0.000183	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	1.65e-05	0.000183	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	1.65e-05	0.000183	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.64e-05	0.000183	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	1.64e-05	0.000182	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	1.63e-05	0.000181	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	1.63e-05	0.000181	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	1.62e-05	0.00018	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	1.58e-05	0.000175	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	1.56e-05	0.000173	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	1.54e-05	0.000171	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	1.53e-05	0.00017	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	1.53e-05	0.00017	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	1.52e-05	0.000169	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	1.51e-05	0.000168	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	1.5e-05	0.000167	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	1.5e-05	0.000167	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	1.5e-05	0.000166	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	1.5e-05	0.000166	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	1.49e-05	0.000166	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	1.46e-05	0.000163	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	1.46e-05	0.000162	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	1.46e-05	0.000162	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	1.44e-05	0.000159	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	1.43e-05	0.000159	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	1.42e-05	0.000158	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.42e-05	0.000157	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	1.41e-05	0.000157	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.41e-05	0.000156	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—APOE—multiple sclerosis	1.41e-05	0.000156	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	1.4e-05	0.000155	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	1.4e-05	0.000155	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	1.39e-05	0.000155	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	1.39e-05	0.000154	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	1.38e-05	0.000154	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	1.37e-05	0.000152	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	1.37e-05	0.000152	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	1.36e-05	0.000152	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	1.36e-05	0.000151	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	1.35e-05	0.00015	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	1.35e-05	0.00015	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—APOE—multiple sclerosis	1.35e-05	0.00015	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	1.33e-05	0.000148	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.33e-05	0.000148	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.32e-05	0.000147	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.31e-05	0.000146	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	1.31e-05	0.000145	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	1.29e-05	0.000144	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.27e-05	0.000142	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	1.27e-05	0.000142	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	1.27e-05	0.000141	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	1.26e-05	0.00014	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	1.26e-05	0.00014	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	1.26e-05	0.00014	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.25e-05	0.000139	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	1.25e-05	0.000139	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	1.24e-05	0.000138	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.24e-05	0.000137	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.23e-05	0.000137	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.22e-05	0.000135	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.22e-05	0.000135	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—POMC—multiple sclerosis	1.21e-05	0.000134	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	1.2e-05	0.000133	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.18e-05	0.000132	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	1.18e-05	0.000131	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	1.17e-05	0.00013	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.17e-05	0.000129	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.16e-05	0.000129	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—POMC—multiple sclerosis	1.16e-05	0.000129	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.16e-05	0.000129	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.15e-05	0.000127	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—APOE—multiple sclerosis	1.14e-05	0.000127	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	1.14e-05	0.000126	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.13e-05	0.000126	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.13e-05	0.000126	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.11e-05	0.000124	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.11e-05	0.000123	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.11e-05	0.000123	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—ALB—multiple sclerosis	1.1e-05	0.000122	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1.08e-05	0.00012	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.08e-05	0.00012	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	1.06e-05	0.000118	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	1.06e-05	0.000118	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	1.06e-05	0.000118	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—ALB—multiple sclerosis	1.06e-05	0.000117	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.05e-05	0.000117	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.05e-05	0.000116	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—APOE—multiple sclerosis	1.05e-05	0.000116	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	1.05e-05	0.000116	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.04e-05	0.000115	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.04e-05	0.000115	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.03e-05	0.000114	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.03e-05	0.000114	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	1.01e-05	0.000112	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	9.95e-06	0.00011	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—APOE—multiple sclerosis	9.89e-06	0.00011	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	9.89e-06	0.00011	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—POMC—multiple sclerosis	9.82e-06	0.000109	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	9.73e-06	0.000108	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	9.67e-06	0.000107	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	9.61e-06	0.000107	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	9.56e-06	0.000106	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	9.52e-06	0.000106	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	9.3e-06	0.000103	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—POMC—multiple sclerosis	9e-06	9.99e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	8.98e-06	9.97e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—ALB—multiple sclerosis	8.95e-06	9.94e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	8.86e-06	9.84e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	8.84e-06	9.81e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	8.83e-06	9.81e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	8.82e-06	9.79e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	8.64e-06	9.6e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	8.64e-06	9.59e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—POMC—multiple sclerosis	8.5e-06	9.44e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	8.46e-06	9.39e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	8.38e-06	9.31e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	8.21e-06	9.12e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—ALB—multiple sclerosis	8.2e-06	9.11e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.09e-06	8.99e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	8.03e-06	8.92e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	8e-06	8.88e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	7.96e-06	8.84e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOE—multiple sclerosis	7.9e-06	8.78e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	7.86e-06	8.73e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	7.85e-06	8.72e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ALB—multiple sclerosis	7.75e-06	8.61e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	7.57e-06	8.41e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	7.47e-06	8.3e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	7.46e-06	8.28e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOE—multiple sclerosis	7.45e-06	8.27e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	7.43e-06	8.26e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	7.35e-06	8.17e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	7.32e-06	8.13e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	7.29e-06	8.1e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	7.07e-06	7.85e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	6.96e-06	7.73e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	6.93e-06	7.69e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	6.91e-06	7.67e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—POMC—multiple sclerosis	6.79e-06	7.54e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	6.78e-06	7.53e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	6.73e-06	7.48e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	6.53e-06	7.25e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	6.5e-06	7.22e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—POMC—multiple sclerosis	6.4e-06	7.1e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOE—multiple sclerosis	6.31e-06	7.01e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	6.29e-06	6.98e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	6.25e-06	6.95e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	6.24e-06	6.93e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ALB—multiple sclerosis	6.19e-06	6.87e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	6.19e-06	6.87e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	6.18e-06	6.87e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	6.12e-06	6.8e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	6.07e-06	6.74e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	6.04e-06	6.71e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	5.84e-06	6.49e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ALB—multiple sclerosis	5.83e-06	6.48e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	5.83e-06	6.47e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	5.75e-06	6.39e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	5.74e-06	6.38e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	5.74e-06	6.37e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	5.72e-06	6.35e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	5.62e-06	6.25e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	5.5e-06	6.1e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—POMC—multiple sclerosis	5.42e-06	6.02e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	5.21e-06	5.78e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	5.11e-06	5.67e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	5.11e-06	5.67e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	5.09e-06	5.66e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	5e-06	5.55e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALB—multiple sclerosis	4.94e-06	5.49e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOE—multiple sclerosis	4.87e-06	5.41e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	4.75e-06	5.27e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	4.73e-06	5.26e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	4.7e-06	5.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	4.64e-06	5.16e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	4.39e-06	4.88e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	4.32e-06	4.8e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—POMC—multiple sclerosis	4.18e-06	4.64e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	3.84e-06	4.26e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALB—multiple sclerosis	3.81e-06	4.23e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	3.57e-06	3.96e-05	CbGpPWpGaD
